These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 45088)

  • 21. [In vitro activity of cefaclor against Haemophilus influenzae in comparison to various oral chemotherapeutic agents (author's transl)].
    Braveny I
    Infection; 1979; 7 Suppl 6():532-9. PubMed ID: 317812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global surveillance of bacterial susceptibility to cefaclor: 1988-1990.
    Preston DA
    Clin Ther; 1993; 15(1):88-96. PubMed ID: 8458058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The antibacterial efficacy of cefaclor in routine testing of clinical material from two Berlin hospitals (author's transl)].
    Wagner J; Hahn H
    Infection; 1979; 7 Suppl 6():547-50. PubMed ID: 121730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefaclor: clinical and bacteriological evaluation in 45 cases.
    Gómez-Lus R; Martinez-Piriz R; Espinosa C; Guillen G; Gómez-Agudo G; Clavel A
    Postgrad Med J; 1979; 55 Suppl 4():70-1. PubMed ID: 44909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriological in vitro investigations with cefaclor. Correlation of inhibition zone diameter and minimal inhibitory concentration (author's transl)].
    Grimm H
    Infection; 1979; 7 Suppl 6():540-2. PubMed ID: 399245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
    Kamimura T; Kojo H; Matsumoto Y; Mine Y; Goto S; Kuwahara S
    Antimicrob Agents Chemother; 1984 Jan; 25(1):98-104. PubMed ID: 6561017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity.
    Chabbert YA; Lutz AJ
    Antimicrob Agents Chemother; 1978 Nov; 14(5):749-54. PubMed ID: 31836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
    Jones RN; Barry AL
    J Antimicrob Chemother; 1988 Sep; 22(3):315-20. PubMed ID: 3182429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
    Dillon HC; Gray BM; Ware JC
    Postgrad Med J; 1979; 55 Suppl 4():77-81. PubMed ID: 548944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of Haemophilus influenzae type b to cefaclor and influence of inoculum size.
    Levin RM; Azimi PH; Dunphy MG
    Antimicrob Agents Chemother; 1982 Nov; 22(5):923-5. PubMed ID: 6983863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of LY163892, cefaclor, and cefuroxime.
    Knapp CC; Washington JA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):131-3. PubMed ID: 3348605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of BMY 28100, a new oral cephalosporin.
    Steele J; Edwards B; Rissing J
    Eur J Clin Microbiol; 1987 Feb; 6(1):111-3. PubMed ID: 3494601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
    Diagn Microbiol Infect Dis; 1986 Jul; 5(2):151-62. PubMed ID: 3522088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antimicrobial activity of cephalexin against old and new pathogens.
    Jones RN; Preston DA
    Postgrad Med J; 1983; 59 Suppl 5():9-15. PubMed ID: 6364091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity and beta-lactamase stability of LY163892.
    Pelosi E; Fontana R
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):549-51. PubMed ID: 3141170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.
    Ripa S; Prenna M
    Chemotherapy; 1979; 25(1):9-13. PubMed ID: 33784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
    Nies BA
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):558-61. PubMed ID: 2504600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT; Chao HP; Ho SW; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)].
    Schassan HH
    Infection; 1979; 7 Suppl 6():527-31. PubMed ID: 399243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.